Sympathetic mechanisms, organ damage, and antihypertensive treatment (Q37859637)

24 August 2017

1 reference

title

Sympathetic mechanisms, organ damage, and antihypertensive treatment (English)

1 reference

24 August 2017

4

Giuseppe Mancia

1 reference

24 August 2017

1

Guido Grassi

1 reference

24 August 2017

Gino Seravalle

2

1 reference

PubMed ID

21451943

24 August 2017

Raffaella Dell'Oro

series ordinal

3

1 reference

24 August 2017

1 August 2011

1 reference

Current Hypertension Reports

24 August 2017

1 reference

24 August 2017

13

1 reference

24 August 2017

303-308

1 reference

24 August 2017

4

1 reference

https://scigraph.springernature.com/pub.10.1007/s11906-011-0200-4

24 August 2017

0 references

cites work

Sympathetic activation in the pathogenesis of hypertension and progression of organ damage

1 reference

https://api.crossref.org/works/10.1007%2FS11906-011-0200-4

Pathways involved in the transition from hypertension to hypertrophy to heart failure. Treatment strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-011-0200-4

The 'neuroadrenergic hypothesis' in hypertension: current evidence.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-011-0200-4

Norepinephrine-induced changes in cardiac transforming growth factor-beta isoform expression pattern of female and male rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-011-0200-4

Sympathetic nervous system modulation of inflammation and remodeling in the hypertensive heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-011-0200-4

Sympathectomy or doxazosin, but not propranolol, blunt myocardial interstitial fibrosis in pressure-overload hypertrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-011-0200-4

Relation between cardiac sympathetic activity and hypertensive left ventricular hypertrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-011-0200-4

Relationship between central sympathetic drive and magnetic resonance imaging-determined left ventricular mass in essential hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-011-0200-4

Sympathetic and reflex abnormalities in heart failure secondary to ischaemic or idiopathic dilated cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-011-0200-4

Sympathetic and baroreflex function in hypertensive or heart failure patients with ventricular arrhythmias

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-011-0200-4

Effect of cardiac sympathetic nervous activity on mode of death in congestive heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-011-0200-4

Behaviour of the adrenergic cardiovascular drive in atrial fibrillation and cardiac arrhythmias

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-011-0200-4

Effects of Hypertension and Obesity on the Sympathetic Activation of Heart Failure Patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-011-0200-4

Sympathetic tone restrains arterial distensibility of healthy and atherosclerotic subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-011-0200-4

Physiology in perspective: The Wisdom of the Body. Neural control of the kidney

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-011-0200-4

Translational medicine: the antihypertensive effect of renal denervation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-011-0200-4

Sympathetic nerve activity in end-stage renal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-011-0200-4

Plasma norepinephrine predicts survival and incident cardiovascular events in patients with end-stage renal disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-011-0200-4

Analysis of the relationship between norepinephrine and asymmetric dimethyl arginine levels among patients with end-stage renal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-011-0200-4

2007 ESH-ESC Practice Guidelines for the Management of Arterial Hypertension: ESH-ESC Task Force on the Management of Arterial Hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-011-0200-4

Sympathetic and baroreflex function in hypertension: implications for current and new drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-011-0200-4

Comparative effects of candesartan and hydrochlorothiazide on blood pressure, insulin sensitivity, and sympathetic drive in obese hypertensive individuals: results of the CROSS study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-011-0200-4

Enalapril and losartan reduce sympathetic hyperactivity in patients with chronic renal failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-011-0200-4

Neuroadrenergic effects of calcium channel blockers: a developing concept.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-011-0200-4

Short-versus long-term effects of different dihydropyridines on sympathetic and baroreflex function in hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-011-0200-4

Effect of morning and bedtime dosing with cilnidipine on blood pressure, heart rate, and sympathetic nervous activity in essential hypertensive patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-011-0200-4

Differential effects of chlorthalidone versus spironolactone on muscle sympathetic nerve activity in hypertensive patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-011-0200-4

Aldosterone-receptor antagonism in hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-011-0200-4

How to assess sympathetic activity in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-011-0200-4

Functional role of renal afferents

21 January 2018

1 reference

12 December 2020

Sympathetic and baroreflex cardiovascular control in hypertension-related left ventricular dysfunction

1 reference

12 December 2020

Altered function and structure of the heart in dogs with chronic elevation in plasma norepinephrine

1 reference

12 December 2020

Sympathetic activation and loss of reflex sympathetic control in mild congestive heart failure

1 reference

12 December 2020

Effect of chronic angiotensin converting enzyme inhibition on sympathetic nerve traffic and baroreflex control of the circulation in essential hypertension

1 reference

12 December 2020

Reduced baroreflex effectiveness index in hypertensive patients with chronic renal failure

1 reference

12 December 2020

Renal denervation as a therapeutic approach for hypertension: novel implications for an old concept

1 reference

12 December 2020

Mechanisms of sympathetic overactivity in patients with chronic renal failure: a role for chemoreflex activation?

1 reference

12 December 2020

Hypertensive left ventricular hypertrophy: relation to peripheral sympathetic drive

1 reference

12 December 2020

10.1007/S11906-011-0200-4

Identifiers

DOI

1 reference

24 August 2017

1 reference

PubMed ID

21451943